Real life Effectiveness and safety of an induction treatment with tofacitinib in patients with Ulcerative Colitis: First results of the French TOFAST cohort

被引：0
|
作者：
Fumery, M. [1 ]
Bouhnik, Y. [2 ]
Faure, P. [3 ]
Bouzidi, A. [4 ]
Brault, Y. [4 ]
Peyrin-Biroulet, L. [5 ]
Laharie, D. [6 ]
机构：
[1] CHU Amiens, Gastroenterol & Hepatol, Amiens, France
[2] Groupe Hosp Ambroise Pare Hartmann, Inst MICI, Neuilly sur Seine, France
[3] Clin Pasteur Hepatol & Gastro Enterol, Tououse, France
[4] Pfizer Infammat & Immunol, Paris, France
[5] Univ Hosp, Gastroenterol, Nancy, France
[6] CHU Bordeaux, Hepatol & Gastroenterol, Bordeaux, France
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P450
引用
收藏
页码：580 / 581
页数：2
相关论文
共 50 条
  • [21] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - UPDATED RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
    Sands, Bruce E.
    Taub, Pam R.
    Feagan, Brian G.
    Armuzzi, Alessandro
    Damiao, Aderson O.
    Lawendy, Nervin
    Solano, Gaston
    Kwok, Kenneth
    Woolcott, John
    Salese, Leonardo
    Su, Chinyu
    GASTROENTEROLOGY, 2020, 158 (06) : S1190 - S1190
  • [22] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE TOFACITINIB OCTAVE ULCERATIVE COLITIS CLINICAL PROGRAM
    Vermeire, Severine
    Armuzzi, Alessandro
    Kwok, Kenneth K.
    Lawendy, Nerrvin
    Woolcott, John
    Salese, Leonardo
    Su, Chinyu
    Hudesman, David
    GASTROENTEROLOGY, 2021, 160 (06) : S353 - S353
  • [23] Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
    Taxonera, Carlos
    Olivares, David
    Alba, Cristina
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) : 32 - 40
  • [24] Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study
    Amiot, A.
    Vered, A.
    Filippi, J.
    Cadiot, G.
    Laharie, D.
    Melanie, S.
    Altwegg, R.
    Bouhnik, Y.
    Peyrin-biroulet, L.
    Gilletta, C.
    Roblin, X.
    de Chambrun, G. Pineton
    Vuitton, L.
    Bourrier, A.
    Nancey, S.
    Gornet, J. M.
    Nahon, S.
    Bouguen, G.
    Viennot, S.
    Benjamin, P.
    Fumery, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S579 - S579
  • [25] Safety and persistence oh the first JAK inhibitor Tofacitinib in patients with ulcerative colitis
    Gonzalez Chavez, J.
    Santos Fagundo, A.
    Ceballos Santos, D.
    Calzado Gomez, G.
    Gonzalez Perez, Y.
    Morales Leon, V.
    Otazo Perez, S. M.
    Hernandez Camba, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1092 - I1092
  • [26] Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland
    Perrig, Kathrin
    Krupka, Niklas
    Jordi, Sebastian Bruno Ulrich
    Rossel, Jean-Benoit
    Biedermann, Luc
    Greuter, Thomas
    Schreiner, Philipp
    Vavricka, Stephan R.
    Juillerat, Pascal
    Burri, Emanuel
    Zimmermann, Dorothee
    Maillard, Michel H.
    Sulz, Michael Christian
    Brand, Stephan
    Rogler, Gerhard
    Misselwitz, Benjamin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [27] Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study
    Amiot, Aurelien
    Filippi, Jerome
    Abitbol, Vered
    Cadiot, Guillaume
    Laharie, David
    Serrero, Melanie
    Altwegg, Romain
    Bouhnik, Yoram
    Peyrin-Biroulet, Laurent
    Gilletta, Cyrielle
    Roblin, Xavier
    de Chambrun, Guillaume Pineton
    Vuitton, Lucine
    Bourrier, Anne
    Nancey, Stephane
    Gornet, Jean-Marc
    Nahon, Stephane
    Bouguen, Guillaume
    Viennot, Stephanie
    Pariente, Benjamin
    Fumery, Mathurin
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1039 - 1046
  • [28] Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis
    Singh D.m., A.
    Midha, V
    Bhardwaj, A.
    Sharma, R.
    Singh, D.
    Mahajan, R.
    Sood, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1678 - i1678
  • [29] Results from the UPITA-Colitis Registry on the Effectiveness and Safety of Upadacitinib in the Induction phase in Patients with Ulcerative Colitis
    Caballero Mateos, A. M.
    Gonzalez-Parra, A. C.
    Gutierrez-Holanda, C.
    Trapero-Martinez, A. M.
    Hernandez-Martinez, A.
    Rojas-Feria, M.
    Martin-Rodriguez, M. D. M.
    Rodriguez-Gonzalez, F. J.
    Saldana, L.
    Benitez, J. M.
    Gomez-Delgado, E.
    Miras, L.
    Gonzalez, J.
    Mata, F. J.
    Olmedo-Martin, R., V
    GATE, II
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2042 - i2044
  • [30] Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis
    Fabrizio Bossa
    Giuseppe Biscaglia
    Maria Rosa Valvano
    Giuseppe Costantino
    Angelo Lauria
    Rocco Clemente
    Concetta Ferracane
    Endrit Shahini
    Marco Mendolaro
    Laurino Grossi
    Silvia Mazzuoli
    Antonio Rispo
    Giuseppe Pranzo
    Ladislava Sebkova
    Antonio Tursi
    Agnese Miranda
    Marta Patturelli
    Rocco Spagnuolo
    Cristina Ricciardelli
    Caterina Sgarro
    Pietro Paese
    Gaetano Inserra
    Alessandro Azzarone
    Olga Nardone
    Walter Fries
    Nello Buccianti
    Antonino Carlo Privitera
    Maria Beatrice Principi
    Maria Cappello
    Francesco William Guglielmi
    Marco Romano
    Gabriele Riegler
    Libera Fanigliulo
    Raffaele Melina
    Angelo Andriulli
    Digestive Diseases and Sciences, 2020, 65 : 1767 - 1776
12345